Date: May 30, 2018
Medical Disposables & Supplies Limited (MDS), for the Year ending March 31, 2018 reported Revenue of $2.04 billion, an increase of 19% compared to the $1.71 billion booked in 2017. Cost of Sales increased $280.63 million to total $1.58 billion relative to $1.30 billion in 2017, a 22% increase. As a result, Gross Profit grew by 12% or $50.79 million to total $461.52 million in 2018 compared to $410.73 million in 2017. Revenue for the fourth quarter amounted to $559.46 million up 23% (2017: $455.65 million).
Total Operating Cost rose 16% to close at $324.10 million (2017: $279.42 million). Of this total, Selling and Promotional costs rose by 25% to $127.85 million relative to $102.58 million in 2017. Administrative Expenses went up by 12% to close the year at $171.09 million (2017: $152.22 million). Other Operating Expenses decreased by15% to close the year at $2.12 million (2017: $2.48 million), while depreciation increased by 4% to close the year at $23.05 million (2017: $22.13 million). For the fourth quarter Total Operating Cost amounted $76.47 million (2016: $68.31 million).
Operating Profit closed at $141.80 million relative to $135.58 million in 2017 this represents a 5% increase. The company reported Finance Income of $23,204 for the period, this compares with the $95,404 booked for 2017.
Finance Cost for the year amounted to $35.31 million relative to the $34.30 million reported in 2017.
Foreign Exchange Gains of $2.65 million were reported for the year relative to a loss of $743,304 in 2017.
Pre-tax profit totalled $109.65 million, up from the $100.63 million booked the year prior, a 9% increase. After taxation of $60,000, Profit after Tax rose 9% amounting to $109.59 million compared to $100.57 million in 2017. For the fourth quarter Net Profits totalled $46.13 million (2017: $33.77 million).
Earnings per Share for the year amounted $0.42 (2016: $0.38), while EPS for the quarter totalled $0.18 relative to $0.13 last year. The number of shares used in the calculation was 263,157,895. MDS stock price last traded on May 30, 2018 at $4.50.
Balance Sheet at a glance:
As at March 31, 2018, Total Assets rose by 21% amounting to $1.47 billion (2017: $1.21 billion). This was due to an increase in the company’s ‘Inventories’ and ‘Trade and other receivables’ which ended the period at $543.78 million (2017:$369.38 million) and $382.57 million (2017: $324.62 million).
Shareholders’ equity totalled $673.13 million (2017: $563.54 million) with book value per share of $2.56 (2017: $2.14).
Disclaimer:
Analyst Certification -The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation (s) or view (s) expressed by that research analyst in this research report.
Company Disclosure -The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may effect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.
